Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wright

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Plos One|June 4, 2010
Genomic diversity and introgression in O. sativa reveal the impact of domestication and breeding on the rice genomeKeyan Zhao, Mark Wright, Jennifer Kimball, et al.
Frontline Gastroenterology|April 14, 2023
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)Richard J Aspinall, Mark Hudson, Stephen D Ryder, et al.
Hepatology (Baltimore, Md.)|December 3, 2003
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infectionSimon Hellier, Angela J Frodsham, Branwen J W Hennig, et al.
Frontline Gastroenterology|July 11, 2022
Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus documentLucia Macken, Margaret Corrigan, Wendy Prentice, et al.
Health Technology Assessment (Winchester, England)|March 23, 2019
Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort studyMartin C Gulliford, Dorota Juszczyk, A Toby Prevost, et al.
BMJ (Clinical Research Ed.)|February 14, 2019
Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trialMartin C Gulliford, A Toby Prevost, Judith Charlton, et al.
Trials|August 21, 2013
Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trialEwan Forrest, Jane Mellor, Louise Stanton, et al.
Gastroenterology|January 4, 2017
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNANikhil Vergis, Stephen R Atkinson, Suzanne Knapp, et al.
Medical Physics|November 18, 2024
A radiation therapy platform to enable upright cone beam computed tomography and future upright treatment on existing photon therapy machinesJames C Korte, Mark Wright, Prem G Krishnan, et al.
Contemporary Clinical Trials|May 23, 2018
Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver diseaseEleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Plos One|June 4, 2010
Genomic diversity and introgression in O. sativa reveal the impact of domestication and breeding on the rice genomeKeyan Zhao, Mark Wright, Jennifer Kimball, et al.
Frontline Gastroenterology|April 14, 2023
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)Richard J Aspinall, Mark Hudson, Stephen D Ryder, et al.
Hepatology (Baltimore, Md.)|December 3, 2003
Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infectionSimon Hellier, Angela J Frodsham, Branwen J W Hennig, et al.
Frontline Gastroenterology|July 11, 2022
Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus documentLucia Macken, Margaret Corrigan, Wendy Prentice, et al.
Health Technology Assessment (Winchester, England)|March 23, 2019
Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort studyMartin C Gulliford, Dorota Juszczyk, A Toby Prevost, et al.
BMJ (Clinical Research Ed.)|February 14, 2019
Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trialMartin C Gulliford, A Toby Prevost, Judith Charlton, et al.
Trials|August 21, 2013
Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trialEwan Forrest, Jane Mellor, Louise Stanton, et al.
Gastroenterology|January 4, 2017
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNANikhil Vergis, Stephen R Atkinson, Suzanne Knapp, et al.
Medical Physics|November 18, 2024
A radiation therapy platform to enable upright cone beam computed tomography and future upright treatment on existing photon therapy machinesJames C Korte, Mark Wright, Prem G Krishnan, et al.
Contemporary Clinical Trials|May 23, 2018
Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver diseaseEleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, et al.
Pageof 13